AnGes (TSE:4563) EV-to-FCF: (As of Jul. 08, 2026)


TSE:4563 AnGes Inc TSE:4563
53 GF Score
Price 円52.00
GF Value 円96.12
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is AnGes EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, AnGes's Enterprise Value is 円20,425.0 Mil. AnGes's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was 円0.0 Mil. Therefore, AnGes's EV-to-FCF for today is .

The historical rank and industry rank for AnGes's EV-to-FCF or its related term are showing as below:

TSE:4563' s EV-to-FCF Range Over the Past 10 Years
Min: -3.2   Med: 0   Max: 0
Current: -3.2

TSE:4563's EV-to-FCF is ranked worse than
100% of 327 companies
in the Biotechnology industry
Industry Median: 16.69 vs TSE:4563: -3.20

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2026-07-08), AnGes's stock price is 円52.00. AnGes's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was 円-13.190. Therefore, AnGes's PE Ratio (TTM) for today is At Loss.


AnGes  (TSE:4563) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

AnGes's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=52.00/-13.190
=At Loss

AnGes's share price for today is 円52.00.
AnGes's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was 円-13.190.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


AnGes EV-to-FCF Related Terms


AnGes EV-to-FCF Historical Data

* Premium members only.

The historical data trend for AnGes's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AnGes EV-to-FCF Chart

AnGes Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only -3.57 -1.06 -1.19 -2.05 -3.80

AnGes Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 -3.80 0.00

TSE:4563 vs VRTX, REGN, ALNY: EV-to-FCF Comparison

For the Biotechnology subindustry, AnGes's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AnGes EV-to-FCF vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, AnGes's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where AnGes's EV-to-FCF falls into.


TSE:4563
53GF Score
AnGes Inc TSE:4563
EV-to-FCF is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

AnGes EV-to-FCF Calculation

AnGes's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=20425.033/0
=

AnGes's current Enterprise Value is 円20,425.0 Mil.
AnGes's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Is AnGes (TSE:4563) Overvalued in 2026?

Based on GuruFocus' analysis, AnGes stock appears to be undervalued. The current stock price of 円52.00 is trading 45.9% below its estimated GF Value™ of 円96.12. GuruFocus considers AnGes to be Possible Value Trap.

Key valuation signals for TSE:4563:

  • EV-to-FCF:
  • GF Value™: 円96.12 vs. price of 円52.00 (45.9% below fair value)
  • GF Score™: 53/100 with 5 warning signs

No single metric tells the full story. See the TSE:4563 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


AnGes Business Description

Other Exchanges AJW:Germany
Address 7-7-15, Saito-asagi, 4F, Saito Bio-Incubator, Ibaraki, Osaka, JPN, 567-0085
AnGes Inc is a biopharmaceutical company. The company is involved in research and development and sales of pharmaceuticals such as gene-based drugs (gene therapy products, nucleic acid drugs); contract testing for rare genetic diseases, etc.
53GF Score

Get the complete analysis for TSE:4563

EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円52.00
Price
円96.12
GF Value